Concepedia

Paolo Bonvini

PB

26

Publications

1.2K

Citations

19

H-Index

1994

Active since

Affiliations

University of Padua(Current)

Città della Speranza Foundation

Azienda Ospedale - Università Padova

Istituti di Ricovero e Cura a Carattere Scientifico

National Institutes of Health

Paolo Bonvini is an author at University of Padua specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1994–2022

26

Publications

26

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2:  A Successful Example of a Virtual Screening Application

Giorgio Cozza, Paolo Bonvini, Elisa Zorzi et al. · Journal of Medicinal Chemistry · 2006 · 150 citations · Full text

Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin

Eun Joo Chung, Sang‐Gu Hwang, Phuongmai Nguyen et al. · Blood · 2002 · 132 citations · Full text

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.

Paolo Bonvini, T. Gastaldi, Brunangelo Falini et al. · PubMed · 2002 · 131 citations

, , +21

Ubiquitination and Proteasomal Degradation of Nucleophosmin-Anaplastic Lymphoma Kinase Induced by 17-Allylamino-Demethoxygeldanamycin

Paolo Bonvini, Henry Dalla Rosa, Nadia Vignes et al. · Cancer Research · 2004 · 92 citations

Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.

Paolo Bonvini, W G An, A Rosolen et al. · PubMed · 2001 · 78 citations

, , +22

Rows per page

1–5 of 26